Skip to main content
. 2012 Sep 27;176(8):708–719. doi: 10.1093/aje/kws130

Table 5.

Rates of Cardiovascular Events by Recent and Past Medication Use, Baltimore, Maryland, 1987–2010

Subgroup of Medication Use Observed No. of CVEs Person-Years of Follow-up Rate of Events per 1,000 Person- Years Rate Ratio Adjusted for Agea 95% CI P Adjusted for Agea
Hydroxychloroquine useb
 Never 46 2,570 17.9 1.00 Referent
 Past (not current) 20 984 20.3 1.13 0.67, 1.91 0.65
 Currently used but for <6 consecutive months 14 827 16.9 1.02 0.56, 1.86 0.95
 Current use for ≥6 consecutive months 54 5,104 10.6 0.54 0.36, 0.79 0.0019
No. of prior months on hydroxychloroquine
 <12 26 1,594 16.3 0.58 0.40, 0.86 0.99
 ≥12 62 5,322 11.7 1.00 0.62, 1.62 0.0057
NSAID useb
 Never 52 4,106 12.7 1.00 Referent
 Past (not current) 46 2,761 16.7 1.17 0.69, 1.56 0.45
 Current 36 2,616 13.8 0.94 0.70, 1.60 0.78
No. of prior months on NSAIDs
 <12 21 2,129 9.8 1.21 0.83, 1.75 0.34
 ≥12 61 3,298 18.9 0.78 0.47, 1.30 0.32
Immunosuppresant useb
 Never 56 4,646 12.1 1.00 Referent
 Past (not current) 5 304 16.4 1.25 0.50, 3.13 0.63
 Current 73 4,535 16.1 1.43 1.01, 2.03 0.044
No. of prior months on immunosuppressants
 <12 17 862 19.7 1.92 1.11, 3.31 0.019
 ≥12 61 3,976 15.3 1.32 0.92, 1.90 0.13
Aspirin useb
 Never 80 6,743 11.9 1.00 Referent
 Past (not current) 22 1,160 19.0 1.5 1.0, 2.5 0.068
 Current 32 1,583 20.2 1.4 0.9, 2.1 0.11
No. of prior months on Aspirin
 <12 30 1,218 24.6 2.1 1.4, 3.3 0.0004
 ≥12 24 1,525 15.7 1.0 0.7, 1.6 0.89

Abbreviations: CI, confidence interval; CVE, cardiovascular event; NSAID, nonsteroidal anti-inflammatory drug.

a Age refers to the age of the patient at each month of follow-up.

b These do not include use of medications prior to cohort participation.